AASLD
Michael R. Lucey, MD, FAASLD, will present Tuesday morning’s AASLD State-of-the-Art Lecture "Liver Transplantation for Extended Criteria Recipients." The term ‘extended criteria’ is borrowed from the donor literature and doesn’t have a specific definition, he says. Read more
To make sure attendees catch the most thought-provoking research at #DDW19, representatives from each of the four sponsoring societies will highlight the meeting’s top abstracts during Tuesday afternoon’s "Best of DDW 2019" session. Read more
“All GI/hepatologists are asked to assist maternal fetal medicine in the care of pregnant women with liver disease, and as the prevalence of HCV increases and screening guidelines change, we are certain to be faced with this clinical dilemma more often,” says Nancy S. Reau, MD, FAASLD, who will co-moderate Tuesday's AASLD C... Read more
Nancy S. Reau, MD, FAASLD, discusses the worldwide prevalence of hepatitis B and hepatitis C during pregnancy, and points to some of the resources available to gastroenterologists treating expectant mothers with viral hepatitis. Read more
Drug-induced liver injury is seen by every practicing gastroenterologist, not just liver specialists, according to Robert J. Fontana, MD, FAASLD, who will moderate Monday’s AASLD State-of-the-Art Lecture "Drug-Induced Liver Injury in the GI Practice." Read more
Varices and variceal hemorrhage are important and challenging complications that lead to decreased survival in patients with cirrhosis. Their proper management will lead to improvement in survival, according to presenters in Monday’s AASLD Clinical Symposium "Update on the Management of Gastroesophageal Varices." Read more
As Monday’s AASLD State-of-the-Art "New Hope for HCC" lecturer Laura Kulik, MD, notes, “15 years ago, an hour on the treatment of liver cancer would have been very difficult.” But now, a one-hour update is not only possible, but important for gastroenterologists. Read more
From his first year of medical school, Elliot B. Tapper, MD, was hooked on hepatology. Learn more about Dr. Tapper — the most rewarding part of his career and who has helped shape his career the most — in this AASLD Speaker Spotlight. Read more
Patients with decompensated cirrhosis are known to have very high rates of hospitalization, putting increasing financial pressure on hospitals and physician groups to prevent these hospitalizations. A Sunday afternoon AASLD symposium — co-chaired by Elliot B. Tapper, MD, and Michael L. Volk, MD — will provide attendees with... Read more
A multidisciplinary panel will discuss current treatment options for benign solid and cystic liver masses, as well as the surgical and nonsurgical treatment options for hepatocellular carcinoma and cholangiocarcinoma during Monday morning’s AASLD symposium "The Management of Liver Masses," co-chaired by Chirag Desai, MD. Read more